TELA TELA Bio

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference.

TELA’s management is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference at 10:30 am ET on August 14th, 2024. Interested parties can access the live and archived webcast at .

About TELA Bio, Inc.

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit .

Investor Contact

Greg Chodaczek

347-620-7010



EN
25/07/2024

Underlying

TELATELA Bio

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TELA Bio

 PRESS RELEASE
Free
TELA TELA BIO

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates ...

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions today reported financial results for the second quarter ended June 30, 2024. Recent Highlights Reported revenue of $16.1 million in the second quarter, representing growth of 11% over the prior year period of 2023;Appointed Greg Firestone as Chief Commercial Officer on May 20, 2024 to drive our...

August 12, 2024 1 EN
 PRESS RELEASE
Free
TELA TELA BIO

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Aug. 09, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 16,000 shares of its common stock to nine newly-hired employees, with a grant date of August 6, 2024 (the "Grant Date"). The restricted stock units were granted purs...

August 9, 2024 1 EN
 PRESS RELEASE
Free
TELA TELA BIO

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Co...

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference. TELA’s management is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference at 10:30 am ET on August 14th, 2024. Interested parties can access the live and archived webcast at . About TELA Bio...

July 25, 2024 1 EN
 PRESS RELEASE
Free
TELA TELA BIO

TELA Bio to Announce Second Quarter 2024 Financial Results

TELA Bio to Announce Second Quarter 2024 Financial Results MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2024 financial results on Monday, August 12, 2024. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Second Quarter Earnings Conference Call and Webcast DetailsInves...

July 22, 2024 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
TTSH Tile Shop Holdi...
PAYC Paycom Software... ... (+10)

InsiderInsights.com Daily Ratings Report: July 2, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

TTSH TILE SHOP HOLDINGS INC.
PAYC PAYCOM SOFTWARE INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
NAD NUVEEN QUALITY MUNICIPAL INCOM
MDB MONGODB INC. CLASS A
PBYI INNOVATIVE ACQUISITIONS CORP
TELA TELA BIO
BIGZ BLACKROCK INNOVATION AND GROWTH TST
EP EMPIRE PETROLEUM CORP
PEO PETROLEUM & RESOURCES CORPORATION
07/03/24 July 3, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch